Page last updated: 2024-09-03

omega-n-methylarginine and Infant, Premature, Diseases

omega-n-methylarginine has been researched along with Infant, Premature, Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aranda, JV; Clyman, RI; Fields, S; Keller, RL; Ofenstein, JP; Tacy, TA	1

Trials

1 trial(s) available for omega-n-methylarginine and Infant, Premature, Diseases

Article	Year
Combined treatment with a nonselective nitric oxide synthase inhibitor (l-NMMA) and indomethacin increases ductus constriction in extremely premature newborns. Pediatric research, 2005, Volume: 58, Issue:6 Topics: Drug Therapy, Combination; Ductus Arteriosus; Ductus Arteriosus, Patent; Enzyme Inhibitors; Female; Humans; Indomethacin; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Nitric Oxide Synthase; omega-N-Methylarginine	2005

Article

Year

Combined treatment with a nonselective nitric oxide synthase inhibitor (l-NMMA) and indomethacin increases ductus constriction in extremely premature newborns.

Pediatric research, 2005, Volume: 58, Issue:6

Topics: Drug Therapy, Combination; Ductus Arteriosus; Ductus Arteriosus, Patent; Enzyme Inhibitors; Female; Humans; Indomethacin; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Nitric Oxide Synthase; omega-N-Methylarginine

2005